SMS Lifesciences India Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for SMS Lifesciences India.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Pharmaceuticals earnings growth | 17.3% |
| Revenue growth rate | n/a |
| Future return on equity | n/a |
| Analyst coverage | None |
| Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Earnings Working Against SMS Lifesciences India Limited's (NSE:SMSLIFE) Share Price Following 25% Dive
Nov 14
Improved Earnings Required Before SMS Lifesciences India Limited (NSE:SMSLIFE) Stock's 58% Jump Looks Justified
Aug 27Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Aug 01SMS Lifesciences India Limited (NSE:SMSLIFE) Stock Catapults 27% Though Its Price And Business Still Lag The Market
Jun 13SMS Lifesciences India (NSE:SMSLIFE) Use Of Debt Could Be Considered Risky
Feb 10There's Reason For Concern Over SMS Lifesciences India Limited's (NSE:SMSLIFE) Massive 30% Price Jump
Jan 05Should Shareholders Reconsider SMS Lifesciences India Limited's (NSE:SMSLIFE) CEO Compensation Package?
Sep 23SMS Lifesciences India (NSE:SMSLIFE) Is Paying Out A Dividend Of ₹1.50
Sep 07SMS Lifesciences India (NSE:SMSLIFE) Has Affirmed Its Dividend Of ₹1.50
Aug 24SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 16SMS Lifesciences India (NSE:SMSLIFE) Will Pay A Dividend Of ₹1.50
Sep 02SMS Lifesciences India (NSE:SMSLIFE) Takes On Some Risk With Its Use Of Debt
Jun 03With EPS Growth And More, SMS Lifesciences India (NSE:SMSLIFE) Is Interesting
May 13SMS Lifesciences India's (NSE:SMSLIFE) Solid Profits Have Weak Fundamentals
Nov 23Is Now The Time To Put SMS Lifesciences India (NSE:SMSLIFE) On Your Watchlist?
Jun 21Is SMS Lifesciences India (NSE:SMSLIFE) Using Too Much Debt?
Feb 22SMS Lifesciences India Limited's (NSE:SMSLIFE) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Jan 04Insider Buying: The SMS Lifesciences India Limited (NSE:SMSLIFE) MD & Executive Director Just Bought 19% More Shares
Nov 27Does SMS Lifesciences India (NSE:SMSLIFE) Have A Healthy Balance Sheet?
Nov 24In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as SMS Lifesciences India has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 9/30/2024 | 3,169 | 219 | 192 | 335 | N/A |
| 6/30/2024 | 3,239 | 179 | N/A | N/A | N/A |
| 3/31/2024 | 3,060 | 91 | 34 | 243 | N/A |
| 12/31/2023 | 2,797 | 49 | N/A | N/A | N/A |
| 9/30/2023 | 3,121 | 46 | -176 | 120 | N/A |
| 6/30/2023 | 3,079 | 67 | N/A | N/A | N/A |
| 3/31/2023 | 3,156 | 115 | -339 | 147 | N/A |
| 12/31/2022 | 3,475 | 189 | N/A | N/A | N/A |
| 9/30/2022 | 3,505 | 172 | -624 | 6 | N/A |
| 6/30/2022 | 3,558 | 247 | N/A | N/A | N/A |
| 3/31/2022 | 3,501 | 253 | -624 | -112 | N/A |
| 12/31/2021 | 3,366 | 213 | N/A | N/A | N/A |
| 9/30/2021 | 3,118 | 216 | -82 | 364 | N/A |
| 6/30/2021 | 2,871 | 147 | N/A | N/A | N/A |
| 3/31/2021 | 2,656 | 136 | -4 | 352 | N/A |
| 12/31/2020 | 2,291 | 106 | N/A | N/A | N/A |
| 9/30/2020 | 2,091 | 76 | -163 | 61 | N/A |
| 6/30/2020 | 2,237 | 79 | N/A | N/A | N/A |
| 3/31/2020 | 2,608 | 102 | -88 | 145 | N/A |
| 12/31/2019 | 3,220 | 127 | N/A | N/A | N/A |
| 9/30/2019 | 3,970 | 188 | N/A | N/A | N/A |
| 6/30/2019 | 4,098 | 195 | N/A | N/A | N/A |
| 3/31/2019 | 3,779 | 178 | 56 | 300 | N/A |
| 12/31/2018 | 2,997 | 146 | N/A | N/A | N/A |
| 9/30/2018 | 2,697 | 119 | N/A | N/A | N/A |
| 6/30/2018 | 2,315 | 85 | N/A | N/A | N/A |
| 3/31/2018 | 2,130 | 65 | N/A | 80 | N/A |
| 12/31/2017 | 2,148 | 72 | N/A | N/A | N/A |
| 6/30/2017 | 2,034 | 90 | N/A | N/A | N/A |
| 3/31/2017 | 2,159 | 129 | N/A | 197 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SMSLIFE's forecast earnings growth is above the savings rate (6.7%).
Earnings vs Market: Insufficient data to determine if SMSLIFE's earnings are forecast to grow faster than the Indian market
High Growth Earnings: Insufficient data to determine if SMSLIFE's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if SMSLIFE's revenue is forecast to grow faster than the Indian market.
High Growth Revenue: Insufficient data to determine if SMSLIFE's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SMSLIFE's Return on Equity is forecast to be high in 3 years time
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/10 05:08 |
| End of Day Share Price | 2025/01/10 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
SMS Lifesciences India Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Kameswari V. S. Chavali | FirstCall Research |